Aquestive Therapeutics, Inc.
AQST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $129 | $61 | $69 | $72 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $12 | $10 | $7 |
| Inventory | $8 | $8 | $7 | $6 |
| Other Curr. Assets | $3 | $1 | $3 | $3 |
| Total Curr. Assets | $152 | $82 | $89 | $88 |
| Property Plant & Equip (Net) | $9 | $9 | $9 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $0 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $3 | $1 | $1 |
| Total NC Assets | $12 | $12 | $13 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $164 | $94 | $102 | $101 |
| Liabilities | – | – | – | – |
| Payables | $11 | $12 | $12 | $10 |
| Short-Term Debt | $8 | $4 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $1 | $1 |
| Other Curr. Liab. | $5 | $6 | $4 | $7 |
| Total Curr. Liab. | $26 | $23 | $18 | $19 |
| LT Debt | $120 | $37 | $39 | $37 |
| Deferred Rev, NC | $20 | $20 | $20 | $20 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $87 | $87 | $85 |
| Total NC Liab. | $142 | $143 | $145 | $143 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $5 |
| Total Liabilities | $168 | $166 | $163 | $162 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$415 | -$400 | -$386 | -$363 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $411 | $327 | $325 | $303 |
| Total Equity | -$4 | -$73 | -$61 | -$60 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $164 | $94 | $102 | $101 |
| Net Debt | -$0 | -$20 | -$30 | -$34 |